# OnCo record paper-lee-ctdna-adjuvant-benefit-localized-pancreatic-ann-oncol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lee-ctdna-adjuvant-benefit-localized-pancreatic-ann-oncol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lee-ctdna-adjuvant-benefit-localized-pancreatic-ann-oncol-2019" ;
  schema:name "Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer"@en ;
  schema:description "In an Australian study of patients having surgery for pancreatic cancer, everyone whose blood still held tumour DNA afterwards relapsed, including those who went on to have chemotherapy, which argues for testing whether such patients need more treatment."@en ;
  schema:url <https://onco.cc/key-papers/paper-lee-ctdna-adjuvant-benefit-localized-pancreatic-ann-oncol-2019/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1093/annonc/mdz200>, <https://pubmed.ncbi.nlm.nih.gov/31250894/> ;
  schema:sameAs <https://doi.org/10.1093/annonc/mdz200> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Lee B, Lipton L, Cohen J, et al." ;
  onco:related <https://onco.cc/biomarkers/ctdna-mrd-positive/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/> ;
  onco:people <https://onco.cc/people/jeanne-tie/> ;
  onco:journals <https://onco.cc/journals/annals-of-oncology/> .